SK287588B6 - Spôsob výroby sférických aglomerátov telitromycínu a použitie týchto aglomerátov - Google Patents

Spôsob výroby sférických aglomerátov telitromycínu a použitie týchto aglomerátov Download PDF

Info

Publication number
SK287588B6
SK287588B6 SK253-2002A SK2532002A SK287588B6 SK 287588 B6 SK287588 B6 SK 287588B6 SK 2532002 A SK2532002 A SK 2532002A SK 287588 B6 SK287588 B6 SK 287588B6
Authority
SK
Slovakia
Prior art keywords
telithromycin
preparation
spherical
clusters
pharmaceutical forms
Prior art date
Application number
SK253-2002A
Other languages
English (en)
Slovak (sk)
Other versions
SK2532002A3 (en
Inventor
Jean-Yves Godard
Val�Rie Rognon-Ravaux
Original Assignee
Aventis Pharma S. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9549351&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK287588(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma S. A. filed Critical Aventis Pharma S. A.
Publication of SK2532002A3 publication Critical patent/SK2532002A3/sk
Publication of SK287588B6 publication Critical patent/SK287588B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK253-2002A 1999-08-26 2000-08-28 Spôsob výroby sférických aglomerátov telitromycínu a použitie týchto aglomerátov SK287588B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9910810A FR2797875B1 (fr) 1999-08-26 1999-08-26 Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques
PCT/FR2000/002393 WO2001014393A2 (fr) 1999-08-26 2000-08-28 Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques

Publications (2)

Publication Number Publication Date
SK2532002A3 SK2532002A3 (en) 2002-09-10
SK287588B6 true SK287588B6 (sk) 2011-03-04

Family

ID=9549351

Family Applications (1)

Application Number Title Priority Date Filing Date
SK253-2002A SK287588B6 (sk) 1999-08-26 2000-08-28 Spôsob výroby sférických aglomerátov telitromycínu a použitie týchto aglomerátov

Country Status (34)

Country Link
US (1) US6825218B1 (es)
EP (1) EP1212336B1 (es)
JP (1) JP4871467B2 (es)
KR (1) KR100718222B1 (es)
CN (1) CN1183151C (es)
AR (1) AR025398A1 (es)
AT (1) ATE255590T1 (es)
AU (1) AU774385B2 (es)
BR (1) BR0013569B1 (es)
CA (1) CA2382497C (es)
CO (1) CO5190666A1 (es)
CZ (1) CZ2002594A3 (es)
DE (1) DE60006976T2 (es)
DK (1) DK1212336T3 (es)
EA (1) EA005080B1 (es)
ES (1) ES2209970T3 (es)
FR (1) FR2797875B1 (es)
HK (1) HK1049167B (es)
HR (1) HRP20020167B1 (es)
HU (1) HU229075B1 (es)
IL (2) IL148128A0 (es)
ME (2) MEP20108A (es)
MX (1) MXPA02001988A (es)
NO (1) NO322622B1 (es)
PL (1) PL204100B1 (es)
PT (1) PT1212336E (es)
RS (1) RS50433B (es)
SI (1) SI1212336T1 (es)
SK (1) SK287588B6 (es)
TR (1) TR200200506T2 (es)
TW (1) TWI272949B (es)
UA (1) UA73523C2 (es)
WO (1) WO2001014393A2 (es)
ZA (1) ZA200201599B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902202D0 (sv) * 1999-06-10 1999-06-10 Astra Ab Production of aggregates
FR2821747B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Suspension de telithromycine a gout masque
US20040013737A1 (en) * 2002-07-19 2004-01-22 Philippe Becourt Taste masked oral composition of telithromycin
WO2004009059A1 (en) * 2002-07-19 2004-01-29 Aventis Pharma S.A. Taste masked oral composition of telithromycin
EP1524966B1 (en) * 2002-07-19 2009-11-25 Aventis Pharma S.A. Taste masked oral composition of telithromycin
EP1610878B1 (en) * 2003-02-21 2014-09-03 University Of Bath Process for the production of particles
WO2005007143A2 (en) * 2003-07-14 2005-01-27 The Board Of Trustees Of The University Of Illinois Use of makrolides and ketolides for the treatment of tuberculosis
WO2007039914A2 (en) * 2005-10-06 2007-04-12 Alembic Limited Novel polymorphs of telithromycin
US20090075917A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched telithromycin
KR101324862B1 (ko) * 2011-07-12 2013-11-01 (주)에이에스텍 클로피도그렐 황산수소염의 구형 입자, 이를 포함하는 약학적 조성물 및 이의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE31635T1 (de) * 1983-06-22 1988-01-15 Univ Ohio State Res Found Herstellung von feinen materialien.
JPH02227130A (ja) * 1989-02-28 1990-09-10 Taisho Pharmaceut Co Ltd 球形微小凍結粒子の製造法
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
HK1049167B (zh) 2005-08-19
CZ2002594A3 (cs) 2002-09-11
EP1212336A2 (fr) 2002-06-12
BR0013569A (pt) 2002-05-14
CA2382497C (fr) 2011-06-28
HK1049167A1 (en) 2003-05-02
FR2797875B1 (fr) 2001-10-19
PL353137A1 (en) 2003-10-20
CN1371386A (zh) 2002-09-25
DK1212336T3 (da) 2004-03-15
HRP20020167A2 (en) 2003-06-30
ES2209970T3 (es) 2004-07-01
ZA200201599B (en) 2003-04-30
PT1212336E (pt) 2004-04-30
WO2001014393A3 (fr) 2001-06-21
KR100718222B1 (ko) 2007-05-15
DE60006976T2 (de) 2004-10-21
HUP0202842A3 (en) 2003-03-28
KR20020033771A (ko) 2002-05-07
MEP20108A (en) 2010-06-10
AU774385B2 (en) 2004-06-24
PL204100B1 (pl) 2009-12-31
SI1212336T1 (en) 2004-04-30
ME00112B (me) 2010-10-10
NO20020926D0 (no) 2002-02-26
AU7018100A (en) 2001-03-19
CN1183151C (zh) 2005-01-05
EA005080B1 (ru) 2004-10-28
JP4871467B2 (ja) 2012-02-08
MXPA02001988A (es) 2002-08-20
RS50433B (sr) 2009-12-31
JP2003507484A (ja) 2003-02-25
HUP0202842A2 (hu) 2003-01-28
YU13202A (sh) 2004-09-03
EA200200294A1 (ru) 2002-08-29
TWI272949B (en) 2007-02-11
TR200200506T2 (tr) 2002-08-21
CA2382497A1 (fr) 2001-03-01
NO322622B1 (no) 2006-11-06
UA73523C2 (uk) 2005-08-15
CO5190666A1 (es) 2002-08-29
WO2001014393A2 (fr) 2001-03-01
AR025398A1 (es) 2002-11-27
EP1212336B1 (fr) 2003-12-03
IL148128A (en) 2006-10-31
SK2532002A3 (en) 2002-09-10
HRP20020167B1 (en) 2006-06-30
IL148128A0 (en) 2002-09-12
NO20020926L (no) 2002-02-26
US6825218B1 (en) 2004-11-30
DE60006976D1 (de) 2004-01-15
FR2797875A1 (fr) 2001-03-02
ATE255590T1 (de) 2003-12-15
BR0013569B1 (pt) 2014-02-25
HU229075B1 (hu) 2013-07-29

Similar Documents

Publication Publication Date Title
JPS62103013A (ja) 薬物のマイクロカプセル封入方法
WO1995005166A1 (en) Procedure for encapsulating nsaids
EP0164959A2 (en) Pharmaceutical composition in sustained release unit dose form and process for its preparation
SK287588B6 (sk) Spôsob výroby sférických aglomerátov telitromycínu a použitie týchto aglomerátov
JP4714836B2 (ja) ５―ａｓａを含有する修飾放出性経口医薬組成物および腸疾患の治療方法
AU1050800A (en) Particles coated with granulated crystalline ibuprofen
CS396391A3 (en) Theophyline-containing retarded preparation
ES2584403T3 (es) Procedimiento de elaboración de microcápsulas entéricas de alginato por gelación iónica que contienen diclofenac o una de sus sales y composición farmacéutica multiparticulada que las contiene
US6589955B2 (en) Pediatric formulation of gatifloxacin
IE902829A1 (en) Microencapsulated taste-masked water-insoluble nsaid drug¹materials
JP2002542027A (ja) マイクロカプセルの製造方法
HU221435B (en) Pellet-based pharmaceutical composition of controlled release with high content of potassium-chloride, and process for it's production
WO2000061109A1 (fr) Procede de production de composition medicamenteuse renfermant un compose medicamenteux hydrophobe basique
CN110381945A (zh) 口服给予的镓（iii）配合物的组合物
Verma et al. Available Online Through Review Article www. ijptonline. com
CA2008005A1 (en) Microencapsulated taste-masked water-insoluble nsaid drug materials

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20150828